Gabelli Health & Wellness Common (GRX)

Add to Watchlists Create an Alert
10.18 +0.05  +0.49% NYSE Sep 18, 3:48PM BATS Real time Currency in USD
View Full Chart
GRX Price Chart

GRX Description

Gabelli Health & Wellness Common is a long only equity fund managed by Gabelli that tracks the S&P Health Care Select Sector TR USD index and has 169.31M USD assets under management. It has an expected distribution yield of 9.53%, a Prospective PE Ratio of 20.63, and a Prospective Price to Book Value of 2.815. The fund has a net expense ratio of 1.99%, turns over its positions 52.10% per year, and is traded on the New York Stock Exchange.

Benchmark Index: S&P Health Care Select Sector TR USD

GRX Key Info

Expense Ratio (6-30-14) 1.99%
Assets Under Management (9-15-14) 169.31M
30-Day Average Volume (9-17-14) 47809.23
Net Asset Value (9-16-14) 11.34
Discount or Premium to NAV (9-15-14) -11.13%
Turnover Ratio (12-31-13) 52.10%

GRX Asset Allocation

Type % Net % Long % Short
Cash 6.12% 6.12% 0.00%
Stock 93.86% 93.86% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.02% 0.02% 0.00%
As of March 31, 2014

GRX Region Exposure

Americas 81.74%
North America 81.74%
Latin America 0.00%
Greater Europe 13.34%
United Kingdom 1.41%
Europe Developed 11.93%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 4.92%
Japan 4.51%
Australasia 0.00%
Asia Developed 0.27%
Asia Emerging 0.15%
Market Classification
% Developed Markets 99.85%
% Emerging Markets 0.15%
As of June 30, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

GRX Stock Sector Exposure

Basic Materials 0.40%
Communication Services 0.00%
Consumer Cyclical 1.46%
Consumer Defensive 42.84%
Energy 0.00%
Financial Services 0.00%
Healthcare 52.48%
Industrials 0.00%
Real Estate 0.18%
Technology 2.64%
Utilities 0.00%
As of March 31, 2014

GRX Stock Market Capitalization

Giant 19.31%
Large 33.26%
Medium 23.94%
Small 7.53%
Micro 9.81%
As of March 31, 2014
View More Holdings

GRX Top 10 Holdings

Name % Weight Price Chg %
US Treasury Bill 3.18% -- --
CVS Caremark Corp 2.81% 81.17 -1.30%
Actavis PLC 2.69% 237.29 +0.08%
Express Scripts 2.49% 74.47 +0.73%
Nestle SA 2.42% 75.49 +0.91%
Hi-Tech Pharmacal Co Inc 2.28% -- --
Johnson & Johnson 2.01% 107.16 +0.91%
DaVita HealthCare Partners Inc 1.71% 74.67 +1.00%
Cooper Companies 1.68% 156.74 -0.42%
Hillshire Brands Co 1.64% 62.96 +0.00%
As of March 31, 2014
Get Quote for
Advertisement

GRX Risk Info

Beta 0.8636
Max Drawdown (6-21-07 to 9-17-14) 65.00%
30 Day Average Volatility 7.87%

GRX Fundamentals

Dividend Yield TTM (9-18-14) 9.53%
Dividend Yield (Prospective) 1.36%
PE Ratio (Prospective) 20.63
PS Ratio (Prospective) 1.003
Price to Book Value (Prospective) 2.815
ROE 14.66%
ROA 5.66%
Number of Holdings 115.00
As of March 31, 2014

GRX Growth Estimates

Forecasted 5 Yr Earnings Growth 10.39%
Forecasted Book Value Growth 7.10%
Forecasted Cash Flow Growth 3.58%
Forecasted Earnings Growth 5.01%
Forecasted Revenue Growth 6.98%
As of March 31, 2014

GRX Performance

  Returns Total Returns
1M 1.80% 3.00%
3M -0.20% 0.98%
6M -1.83% 0.50%
1Y 0.79% 10.68%
3Y 46.90% 88.34%
5Y 72.84% 145.4%
As of Sept. 16, 2014

GRX Flows

1M 0.00
3M 0.00
6M 0.00
YTD 0.00
1Y 18.85M
3Y --
5Y --
As of Jan. 31, 2012
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.